Beta Bionics, Inc. (BBNX) Preferred Stock Liabilities (2023 - 2024)
Beta Bionics (BBNX) posted Preferred Stock Liabilities of $321.4 million for Q4 2024, up 22.8% sequentially from $261.7 million in Q3 2024, and up 22.8% YoY from $261.7 million in Q1 2024.
Beta Bionics, Inc. (BBNX) Preferred Stock Liabilities (2023 - 2024) Analysis & Trends
Beta Bionics (BBNX) has 2 years of Preferred Stock Liabilities data on file, last reported at $321.4 million in Q4 2024.
- Quarterly Preferred Stock Liabilities rose 22.8% year-over-year to $321.4 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $321.4 million (up 22.8% YoY) and the FY2024 annual result came in at $321.4 million, up 22.8% from the prior year.
- Preferred Stock Liabilities rose to $321.4 million in Q4 2024 per BBNX's latest filing, from $261.7 million in the prior quarter.
- The five-year high for Preferred Stock Liabilities was $321.4 million in Q4 2024, with the low at $261.7 million in Q4 2023.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 321.37 Mn |
| Sep 30, 2024 | 261.71 Mn |
| Jun 30, 2024 | 261.71 Mn |
| Mar 31, 2024 | 261.71 Mn |
| Dec 31, 2023 | 261.71 Mn |